# Derek Jellinek

Nangungunang mga yugto ng podcast
Nai-update:

Under The Microscope: ResMed(ASX: RMD) Derek Jellinek, Senior Analyst

In this podcast, Morgans Senior Analyst Derek Jellinek shares a detailed update on ResMed with the network.

Healthcare Sector Preview: Reporting Season, February 2022

Morgans Senior Analyst Dr. Derek Jellinek goes over the key stocks we are looking out for in the Healthcare sector this February Reporting Season. Stocks include; ResMed Inc (ASX:RMD), Pro Medicus (ASX:PME), Healius (ASX:HLS), Virtus Health (ASX:VRT), Monash IVF (ASX:MVF), and CSL Ltd (ASX:CSL). C…

Company Update: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst

Senior Analyst Derek Jellinek shares his thoughts around Cochlear’s (ASX:COH) A$930m capital raise.

Under the microscope: Cochlear (ASX:COH) Derek Jellinek, Senior Analyst

Cochlear (COH) gains FDA’s blessing on multiple products, but nothing appears game-changing.

Under the microscope: Covid-19 Vaccine, Where Are They Now? - Dr. Derek Jellinek, Senior Analyst

Morgans Senior Analyst, Dr. Derek Jellinek, provides a comprehensive update on the Covid-19 Vaccine. Additionally, Derek breaks down the key stakeholders within the race, and how they're currently positioned.

Healthcare Sector Preview: Reporting Season, August 2022

Morgans Senior Analyst Dr. Derek Jellinek previews our stocks under coverage, how they have been performing and expectations heading into reporting season. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.face…

Healthcare Sector Preview: Reporting Season, February 2023

Senior Analyst Dr Derek Jellinek gives an update on the Healthcare sector heading into February's Reporting Season. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.in…

CSL Limited & Cochlear Results Analyst Comments: Reporting Season, February 2023

Senior Analyst Derek Jellinek gives an update on CSL Limited (ASX:CSL) and Cochlear (ASX:COH) following their recent reporting season results. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/Morg…

ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023

Morgans Senior Analyst Dr Derek Jellinek gives an update on ResMed's mixed 4Q, as strong sales across all product lines failed to translate into operating leverage. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook:…

Sonic Healthcare (ASX:SHL) Result - Analyst Comments | Reporting Season, February 2024

Morgans Senior Analyst Derek Jellinek gives his analysis of the 1H FY24 result from Sonic Healthcare (ASX:SHL). Follow our Reporting Season coverage here: https://www.morgans.com.au/reporting-season Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: ww…